Cipla in focus after partnership with MannKind
Most Popular (6 hours)

Soldier injured in J K gunfight

- business-standard

Most Popular (24 hours)

Saina in final of Denmark Open

- heshillongtimes.com

Levante beat Real Madrid 2-1

- heshillongtimes.com

Why hydropower needs a push

- business-standard

Most Popular (a week)

business-standard
5 months ago

Cipla in focus after partnership with MannKind

Cipla announced that it has entered into an exclusive marketing and distribution agreement with US-based MannKind Corporation for Afrezza in India. Afrezza is the only USFDA approved inhaled insulin available for patients suffering from diabetes. The anno

Read on the original site


India win toss, elect to bowl

- news.statetimes.in
Hashtags:   

Cipla

 | 

focus

 | 

after

 | 

partnership

 | 

with

 | 

MannKind

 |